Kelley C L, Rouse D A, Morris S L
Laboratory of Mycobacteria, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Antimicrob Agents Chemother. 1997 Sep;41(9):2057-8. doi: 10.1128/AAC.41.9.2057.
The ahpC genes of 57 clinical isolates and one in vitro mutant of Mycobacterium tuberculosis were evaluated by nucleotide sequence analyses. Although compensatory ahpC promoter mutations were identified in 8 catalase-negative, katG-defective strains, the ahpC genes of 25 catalase-positive, isoniazid-resistant isolates and 25 drug-sensitive strains were not altered.
通过核苷酸序列分析对57株结核分枝杆菌临床分离株和1株体外突变株的ahpC基因进行了评估。虽然在8株过氧化氢酶阴性、katG缺陷型菌株中鉴定出了补偿性ahpC启动子突变,但25株过氧化氢酶阳性、异烟肼耐药分离株和25株药物敏感菌株的ahpC基因未发生改变。